Cargando…
Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses
Two frequent single-nucleotide-polymorphisms (SNPs) are present in the indoleamine 2,3-dioxygenase 2 (IDO2) gene that influence its enzymatic activity. Thus, one SNP (R248W) is associated with a reduction in IDO2 catalytic activity, whereas the other SNP (Y359stop) generates a premature stop codon a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382899/ https://www.ncbi.nlm.nih.gov/pubmed/22754762 |
_version_ | 1782236570466648064 |
---|---|
author | Køllgaard, Tania Klausen, Tobias Wirenfeldt Idorn, Manja Holmgaard, Rikke Bæk Straten, Per thor Andersen, Mads Hald |
author_facet | Køllgaard, Tania Klausen, Tobias Wirenfeldt Idorn, Manja Holmgaard, Rikke Bæk Straten, Per thor Andersen, Mads Hald |
author_sort | Køllgaard, Tania |
collection | PubMed |
description | Two frequent single-nucleotide-polymorphisms (SNPs) are present in the indoleamine 2,3-dioxygenase 2 (IDO2) gene that influence its enzymatic activity. Thus, one SNP (R248W) is associated with a reduction in IDO2 catalytic activity, whereas the other SNP (Y359stop) generates a premature stop codon abolishing activity completely. In the present study, we describe the presence of a specific cellular immune response in the periphery which correlated with the functional status of the IDO2 protein. Hence, the induction of IDO2-specific T cells in peripheral blood requires the presence of a functional IDO2 protein and, consequently, is restricted to individuals that are not homozygous for the stop codon. Furthermore, we detected stronger T-cell responses in donors with the homozygous Y wild type at position 359 when compared with the heterozygous genotype. Interestingly, we found a higher number of immune responses against IDO2 in patients homozygous for the 248W giving reduction in IDO2 activity compared with the 248R. Hence, spontaneous immune responses against IDO2 seem to be correlated with reduced enzymatic activity of IDO2. The patient IDO2 genotype may well influence the outcome of IDO2-based anti-cancer vaccination. |
format | Online Article Text |
id | pubmed-3382899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-33828992012-07-01 Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses Køllgaard, Tania Klausen, Tobias Wirenfeldt Idorn, Manja Holmgaard, Rikke Bæk Straten, Per thor Andersen, Mads Hald Oncoimmunology Research Paper Two frequent single-nucleotide-polymorphisms (SNPs) are present in the indoleamine 2,3-dioxygenase 2 (IDO2) gene that influence its enzymatic activity. Thus, one SNP (R248W) is associated with a reduction in IDO2 catalytic activity, whereas the other SNP (Y359stop) generates a premature stop codon abolishing activity completely. In the present study, we describe the presence of a specific cellular immune response in the periphery which correlated with the functional status of the IDO2 protein. Hence, the induction of IDO2-specific T cells in peripheral blood requires the presence of a functional IDO2 protein and, consequently, is restricted to individuals that are not homozygous for the stop codon. Furthermore, we detected stronger T-cell responses in donors with the homozygous Y wild type at position 359 when compared with the heterozygous genotype. Interestingly, we found a higher number of immune responses against IDO2 in patients homozygous for the 248W giving reduction in IDO2 activity compared with the 248R. Hence, spontaneous immune responses against IDO2 seem to be correlated with reduced enzymatic activity of IDO2. The patient IDO2 genotype may well influence the outcome of IDO2-based anti-cancer vaccination. Landes Bioscience 2012-07-01 /pmc/articles/PMC3382899/ /pubmed/22754762 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Research Paper Køllgaard, Tania Klausen, Tobias Wirenfeldt Idorn, Manja Holmgaard, Rikke Bæk Straten, Per thor Andersen, Mads Hald Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses |
title | Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses |
title_full | Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses |
title_fullStr | Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses |
title_full_unstemmed | Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses |
title_short | Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses |
title_sort | association of a functional indoleamine 2,3-dioxygenase 2 genotype with specific immune responses |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382899/ https://www.ncbi.nlm.nih.gov/pubmed/22754762 |
work_keys_str_mv | AT køllgaardtania associationofafunctionalindoleamine23dioxygenase2genotypewithspecificimmuneresponses AT klausentobiaswirenfeldt associationofafunctionalindoleamine23dioxygenase2genotypewithspecificimmuneresponses AT idornmanja associationofafunctionalindoleamine23dioxygenase2genotypewithspecificimmuneresponses AT holmgaardrikkebæk associationofafunctionalindoleamine23dioxygenase2genotypewithspecificimmuneresponses AT stratenperthor associationofafunctionalindoleamine23dioxygenase2genotypewithspecificimmuneresponses AT andersenmadshald associationofafunctionalindoleamine23dioxygenase2genotypewithspecificimmuneresponses |